ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned

August 18, 1989